A metabolite of mosapride
Related Products
Parent Compound(s)
30048Mosapride (citrate)
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Des-4-fluorobenzyl Mosapride

Item No. 22157

Technical Information
Formal Name
4-amino-5-chloro-2-ethoxy-N-(2-morpholinylmethyl)-benzamide
CAS Number
152013-26-8
Synonyms
  • Des-p-fluorobenzyl Mosapride
Molecular Formula
C14H20ClN3O3
Formula Weight
Purity
≥90%
A solid
Chloroform: slightly solubleMethanol: slightly, heated
SMILES
O=C(C1=CC(Cl)=C(N)C=C1OCC)NCC2OCCNC2
InChi Code
InChI=1S/C14H20ClN3O3/c1-2-20-13-6-12(16)11(15)5-10(13)14(19)18-8-9-7-17-3-4-21-9/h5-6,9,17H,2-4,7-8,16H2,1H3,(H,18,19)
InChi Key
HQOQHUQAQLNFOP-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Wet ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Product Description

    Des-4-fluorobenzyl Mosapride is the primary metabolite of mosapride. Mosapride is a gastroprokinetic agent that enhances upper GI motility by activating serotonin receptor 4 (5-HT4; EC50 = 74.2 nM, in guinea pig ileal longitudinal muscle myenteric plexus).1,2 Mosapride increases canine, equine, and guinea pig colonic motility in vivo.3,4 Formulations containing mosapride are used in human and veterinary medicine to prevent post-surgical- and Parkinson's-induced constipation.4,5.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Mine, Y., Yoshikawa, T., Oku, S., et alComparison of effect of mosapride citrate and existing 5-HT4 receptor agonists on gastrointestinal motility in vivo and in vitro. J. Pharmacol. Exp. Ther. 283(3), 1000-1008 (1997).

    2. Yoshida, N., and Ito, T. Mosapride citrate (AS-4370), a new gastroproltinetic agent, is a partial 5-HT4 receptor agonist in the gut. Neurogastroenterol. Motil. 6(3):, 197-204 (1994).

    3. Yoshida, N., Ito, T., Karasawa, T., et alAS-4370, a new gastrokinetic agent, enhances upper gastrointestinal motor activity in conscious dogs. J. Pharmacol. Exp. Ther. 257(2):, 781-787 (1991).

    4. Okamura, K., Sasaki, N., Yamada, M., et alEffects of mosapride citrate, metoclopramide hydrochloride, lidocaine hydrochloride, and cisapride citrate on equine gastric emptying, small intestinal and caecal motility. Res. Vet. Sci. 86(2):, 302-308 (2009).

    5. Liu, Z., Sakakibara, R., Odaka, T., et alMosapride citrate, a novel 5-HT4 agonist and partial 5-HT3 antagonist, ameliorates constipation in parkinsonian patients. Mov. Disord. 20(6):, 680-686 (2005).